2015 Conference Publication Immune cell infiltrate subtypes inform on melanoma survival in stage Ib and II melanomasRowe, C., Tang, F., Rodero, M., Malt, M., Lambie, D., Smithers, M., Green, A. and Khosrotehrani, K. (2015). Immune cell infiltrate subtypes inform on melanoma survival in stage Ib and II melanomas. Australasian College of Dermatologists 48th Annual Scientific Meeting, Adelaide, Australia, 16 May 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12337 |
2015 Conference Publication Treatment of oesophageal adenocarcinoma-what is the ideal? Results from a survey of Augis and Anzgosa membersCouper, G., Paterson-Brown, S. and Smithers, M. (2015). Treatment of oesophageal adenocarcinoma-what is the ideal? Results from a survey of Augis and Anzgosa members. 2nd Digestive Disorders Federation Conference, London, England, United Kingdom, Jun 22-25, 2015. London, United Kingdom: B M J Group. doi: 10.1136/gutjnl-2015-309861.598 |
2014 Journal Article Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesisNones, Katia, Waddell, Nicola, Wayte, Nicci, Patch, Ann-Marie, Bailey, Peter, Newell, Felicity, Holmes, Oliver, Fink, J. Lynn, Quinn, Michael C. J., Tang, Yue Hang, Lampe, Guy, Quek, Kelly, Loffler, Kelly A., Manning, Suzanne, Idrisoglu, Senel, Miller, David, Xu, Qinying, Waddell, Nick, Wilson, Peter J., Bruxner, Timothy J. C., Christ, Angelika N., Harliwong, Ivon, Nourse, Craig, Nourbakhsh, Ehsan, Anderson, Matthew, Kazakoff, Stephen, Leonard, Conrad, Wood, Scott, Simpson, Peter T. ... Barbour, Andrew P. (2014). Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nature Communications, 5 (1) 6224, 5224.1-5224.9. doi: 10.1038/ncomms6224 |
2014 Journal Article Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, AustraliaBeesley, Vanessa L., Smithers, B. Mark, Khosrotehrani, Kiarash, Khatun, Modsina, O'Rourke, Peter, Hughes, Maria Celia B., Malt, Maryrose K., Zonta, Mark J., Bayley, Gerard J., Barbour, Andrew P., Brown, Lee J., D'Arcy, Justin, Allan, Christopher and Green, Adèle C. (2014). Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, Australia. Psycho-Oncology, 24 (7), 763-770. doi: 10.1002/pon.3718 |
2014 Journal Article Phase 2 study of intralesional PV-10 in refractory metastatic melanomaThompson, John F., Agarwala, Sanjiv S., Smithers, B. Mark, Ross, Merrick I., Scoggins, Charles R., Coventry, Brendon J., Neuhaus, Susan J., Minor, David R., Singer, Jamie M. and Wachter, Eric A. (2014). Phase 2 study of intralesional PV-10 in refractory metastatic melanoma. Annals of Surgical Oncology, 22 (7), 2135-2142. doi: 10.1245/s10434-014-4169-5 |
2014 Journal Article The Effect on Melanoma Risk of Genes Previously Associated With Telomere LengthIles, Mark M., Bishop, D. Timothy, Taylor, John C., Hayward, Nicholas K., Brossard, Myriam, Cust, Anne E., Dunning, Alison M., Lee, Jeffrey E., Moses, Eric K., Akslen, Lars A., AMFS Investigators, Andresen, Per A., Avril, Marie-Francoise, Azizi, Esther, Scarra, Giovanna Bianchi, Brown, Kevin M., Debniak, Tadeusz, Elder, David E., Friedman, Eitan, Ghiorzo, Paola, Gillanders, Elizabeth M., Goldstein, Alisa M., Gruis, Nelleke A., Hansson, Johan, Harland, Mark, Helsing, Per, Hocevar, Marko, Hoiom, Veronica, IBD investigators ... Visscher, Peter (2014). The Effect on Melanoma Risk of Genes Previously Associated With Telomere Length. JNCI Journal of the National Cancer Institute, 106 (10) dju267. doi: 10.1093/jnci/dju267 |
2014 Journal Article BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapyBarbour, Andrew P., Tang, Yue Hang, Armour, Nicola, Dutton-Regester, Ken, Krause, Lutz, Loffler, Kelly A., Lambie, Duncan, Burmeister, Bryan, Thomas, Janine, Smithers, B. Mark and Hayward, Nicholas K. (2014). BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy. European Journal of Cancer, 50 (15), 2668-2676. doi: 10.1016/j.ejca.2014.06.009 |
2014 Journal Article Coping with esophageal cancer approaches worldwideCotton, Richard G. H., Langer, Rupert, Leong, Trevor, Martinek, Jan, Sewram, Vikash, Smithers, Mark, Swanson, Paul E., Qiao, You-Lin, Udagawa, Harushi, Ueno, Masaki, Wang, Meng, Wei, Wen-Qiang and White, Russell E. (2014). Coping with esophageal cancer approaches worldwide. Annals of the New York Academy of Sciences, 1325 (1), 138-158. doi: 10.1111/nyas.12522 |
2014 Journal Article Controversies in the management of gastrointestinal stromal tumorsYip, Desmond, Zalcberg, John, Ackland, Stephen, Barbour, Andrew P., Desai, Jayesh, Fox, Stephen, Kotasek, Dusan, McArthur, Grant and Smithers, B. Mark (2014). Controversies in the management of gastrointestinal stromal tumors. Asia-Pacific Journal of Clinical Oncology, 10 (3), 216-227. doi: 10.1111/ajco.12187 |
2014 Journal Article Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanomaCoventry, Brendon J., Kroon, Hidde M., Giles, Mitchell H., Henderson, Michael, Speakman, David, Wall, Mark, Barbour, Andrew, Serpell, Jonathan, Paddle, Paul, Coventry, Alexander G.J., Sullivan, Thomas and Smithers, B. Mark (2014). Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma. Journal of Surgical Oncology, 109 (8), 780-785. doi: 10.1002/jso.23590 |
2014 Journal Article Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomyKhosrotehrani, Kiarash, van der Ploeg, Augustinus P.T., Siskind,Victor, Hughes, Maria Celia, Wright, Annaliesa, Thomas, Janine, Barbour, Andrew, Allan, Christopher, Bayley, Gerard, Eggermont, Alexander, Verhoef, Cornelis, Smithers, B. Mark and Green, Adele C. (2014). Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomy. European Journal of Cancer, 50 (7), 1301-1309. doi: 10.1016/j.ejca.2014.02.010 |
2014 Conference Publication Efficacy of intralesional Rose Bengal in patients receiving injection of all existing melanoma in phase II study PV-10-MM-02.Agarwala, Sanjiv S., Thompson, John F., Smithers, B. Mark, Ross, Merrick I., Scoggins, Charles Raben, Coventry, Brendon J., Neuhaus, Susan J., Minor, David R., Singer, Jamie M. and Wachter, Eric Andrew (2014). Efficacy of intralesional Rose Bengal in patients receiving injection of all existing melanoma in phase II study PV-10-MM-02.. 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Chicago Il, May 30-Jun 03, 2014. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
2014 Journal Article Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosisFrankel, Adam, Armour, Nicola, Nancarrow, Derek, Krause, Lutz, Hayward, Nicholas, Lampe, Guy, Smithers, B. Mark and Barbour, Andrew (2014). Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis. Genes Chromosomes and Cancer, 53 (4), 324-338. doi: 10.1002/gcc.22143 |
2014 Journal Article Final trial report of sentinel-node biopsy versus nodal observation in melanomaMorton, D. L., Thompson, J. F., Cochran, A. J., Mozzillo, N., Nieweg, O. E., Roses, D. F., Hoekstra, H. J., Karakousis, C. P., Puleo, C. A., Coventry, B. J., Kashani-Sabet, M., Smithers, B. M., Paul, E., Kraybill ,W. G., McKinnon, J. G., Wang, H.-J., Elashoff, R. and Faries, M. B. (2014). Final trial report of sentinel-node biopsy versus nodal observation in melanoma. New England Journal of Medicine, 370 (7), 599-609. doi: 10.1056/NEJMoa1310460 |
2014 Journal Article Changeable naevi in people at high risk for melanomaAbbott, Nicola C. D., Pandeya, Nirmala, Ong, Natalie, McClenahan, Phil, Smithers, B. Mark, Green, Adele and Soyer, H. Peter (2014). Changeable naevi in people at high risk for melanoma. Australasian Journal of Dermatology, 56 (1), 14-18. doi: 10.1111/ajd.12181 |
2014 Conference Publication Randomized, double-blind phase II trial of NY-ESO-1 ISCOMATRIX vaccine and ISCOMATRIX adjuvant alone in patients with resected stage IIc, III, or IV malignant melanoma.Cebon, Jonathan S., McArthur, Grant A., Chen, Weisan, Davis, Ian D., Gore, Martin Eric, Thompson, John F., Millward, Michael, Findlay, Michael P. N., Dunbar, Rod, Ottensmeier, Christian H. H., Venhaus, Ralph Rudolph, Nathan, Paul D., Dalgleish, Angus George, Cerundolo, Vincenzo, Maraskovsky, Eugene, Hopkins, Wendie, Marsden, Jeremy, Smithers, B. Mark, Hersey, Peter and Evans, T. R. Jeffry (2014). Randomized, double-blind phase II trial of NY-ESO-1 ISCOMATRIX vaccine and ISCOMATRIX adjuvant alone in patients with resected stage IIc, III, or IV malignant melanoma.. 50th Annual Meeting of the American Society of Clinical Oncology, Chicago, Illinois, 30 May - 3 June 2014 . Alexandria, VA, United States: American Society of Clinical Oncology. |
2014 Conference Publication Australian National Multi-Center Study of Isolated Limb Infusion Chemotherapy for Extremity MelanomaKroon, H. M., Coventry, B. J., Giles, M. H., Henderson, M., Smithers, B., Serpell, J. and Thompson, J. F. (2014). Australian National Multi-Center Study of Isolated Limb Infusion Chemotherapy for Extremity Melanoma. 67th Annual Cancer Symposium of the Society-of-Surgical-Oncology, Phoenix Az, Mar 12-15, 2014. New York, United States: Springer New York LLC. doi: 10.1245/s10434-013-3474-8 |
2014 Conference Publication Subgroup Efficacy in Patients Receiving Intralesional Rose Bengal to All Existing Melanoma in Phase II Study Pv-10-Mm-02Agarwala, S., Thompson, J. F., Smithers, B. M., Ross, M., Scoggins, C. R., Coventry, B. J., Neuhaus, S. J., Minor, D. R., Singer, J. M. and Wachter, E. (2014). Subgroup Efficacy in Patients Receiving Intralesional Rose Bengal to All Existing Melanoma in Phase II Study Pv-10-Mm-02. 39th European Society for Medical Oncology Congress (ESMO), Madrid, Spain, 26-30 September 2014. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/annonc/mdu344.36 |
2014 Journal Article Treatment results of curative gastric resection from a specialist Australian unit: Low volume with satisfactory outcomesThomson I.G., Gotley D.C., Barbour A.P., Martin I., Jayasuria N., Thomas J. and Smithers B.M. (2014). Treatment results of curative gastric resection from a specialist Australian unit: Low volume with satisfactory outcomes. Gastric Cancer, 17 (1), 152-160. doi: 10.1007/s10120-013-0240-3 |
2014 Conference Publication Melanoma brain metastases: the impact of nodal diseaseJackson, James E., Burmeister, Bryan H., Burmeister, Elizabeth A., Foote, Matthew C., Thomas, Janine M., Meakin, Janelle A. and Smithers, B. Mark (2014). Melanoma brain metastases: the impact of nodal disease. 54th Annual Scientific Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Boston, MA United States, 28-31 October 2012. Dordrecht, Netherlands: Springer Netherlands. doi: 10.1007/s10585-013-9611-8 |